Robert Kemp
AuthID: R-00K-W5F
1
TITLE: Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study Full Text
AUTHORS: Santoni, Matteo; Myint, Zin W.; Buettner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T.; Gilbert, Danielle; Kueronya, Zsofia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J.; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina Cerrillo, Javier; ...More
PUBLISHED: 2023, SOURCE: CANCER IMMUNOLOGY IMMUNOTHERAPY
AUTHORS: Santoni, Matteo; Myint, Zin W.; Buettner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T.; Gilbert, Danielle; Kueronya, Zsofia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J.; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina Cerrillo, Javier; ...More
PUBLISHED: 2023, SOURCE: CANCER IMMUNOLOGY IMMUNOTHERAPY
INDEXED IN: 
Scopus 
WOS
Scopus WOS